Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $4.61 $6.39 Thursday, 9th May 2024 AFMD stock ended at $5.24. This is 0.0956% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.82% from a day low at $5.14 to a day high of $5.28.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Sep 15, 2016 $28.70 $28.70 $28.70 $28.70 4 070
Sep 14, 2016 $28.50 $28.50 $28.50 $28.50 2 600
Sep 13, 2016 $27.60 $27.60 $27.60 $27.60 6 040
Sep 12, 2016 $29.00 $29.00 $29.00 $29.00 3 390
Sep 09, 2016 $27.90 $27.90 $27.90 $27.90 7 810
Sep 08, 2016 $29.10 $29.10 $29.10 $29.10 15 360
Sep 07, 2016 $28.20 $28.20 $28.20 $28.20 35 770
Sep 06, 2016 $26.00 $26.00 $26.00 $26.00 14 920
Sep 02, 2016 $25.50 $25.50 $25.50 $25.50 3 720
Sep 01, 2016 $25.30 $25.30 $25.30 $25.30 4 020
Aug 31, 2016 $25.10 $25.10 $25.10 $25.10 8 940
Aug 30, 2016 $25.80 $25.80 $25.80 $25.80 2 370
Aug 29, 2016 $25.70 $25.70 $25.70 $25.70 4 000
Aug 26, 2016 $25.50 $25.50 $25.50 $25.50 5 360
Aug 25, 2016 $25.60 $25.60 $25.60 $25.60 6 140
Aug 24, 2016 $25.30 $25.30 $25.30 $25.30 14 470
Aug 23, 2016 $27.80 $27.80 $27.80 $27.80 6 390
Aug 22, 2016 $27.60 $27.60 $27.60 $27.60 6 020
Aug 19, 2016 $26.90 $26.90 $26.90 $26.90 5 880
Aug 18, 2016 $27.30 $27.30 $27.30 $27.30 4 010
Aug 17, 2016 $27.90 $27.90 $27.90 $27.90 13 140
Aug 16, 2016 $27.80 $27.80 $27.80 $27.80 13 250
Aug 15, 2016 $28.70 $28.70 $28.70 $28.70 8 370
Aug 12, 2016 $28.50 $28.50 $28.50 $28.50 21 880
Aug 11, 2016 $29.50 $29.50 $29.50 $29.50 8 380
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT